The Physician Glut -What Does It Portend for Clinical Pharmacy?
RECENT PRONOUNCEMENTS from the federal government, the medical education community and health care planners forecast an approaching, if not imminent, oversupply of physicians in the United States. In a major address to the Association of American Medical Colleges, the Secretary of Health, Education and Welfare has outlined a federal policy strategy that includes a multifocal approach to dealing with the predicted national problem of oversupply of medical manpower. 1 This looming issue was also the subject of a recent article in the New England Journal of Medicine. In short, given the current rate of increase in physician supply and the rate of population growth, the prospect of a severe oversupply of physicians appears inevitable by 1990 or 2000. 2 Addressing this issue is undoubtedly a current major preoccupation of the leadership of the medical community.
Is there any possible portent for pharmacy in this issue? I believe there most certainly is, particularly as it relates to the form and substance of pharmacy's continued attempts at professional role expansion and growth in clinical practice.
There is little doubt that our progress in this area has been remarkable, given a relatively short gestation period. Major gains have been made in both the educational and the institutional practice sectors. As a result of the development of sound practitioner-educator role models, there is a growing nucleus of highly motivated and more clinically trained practitioners. And these individuals are now beginning to assume what we perceive to be their rightful roles in health care delivery.
Our rate of progress and growth to date, however, may to some extent have been a function of the medical community's relatively passive acceptance of a team approach to health care. This is particularly true in academic health science centers and university hospitals, where interdisciplinary patient care and education models have been developed and ultimately diffused into other sectors of the health care community. I do not contend that this passive acceptance and legitimization by medicine has been the major determinant of our success to date. It is only one factor in our assimilation into the "team" thus far, as is the fact that the team concept has become societally sanctioned in virtually every facet of American life (e.g., education and industry). Our progress and growth has in large measure occurred in a period characterized by fewer than desirable numbers and kinds of physicians, many having acquiesced to the team concept.
We may well have deluded ourselves into believing that there is a huge groundswell of advocacy in medicine for such pharmacy role growth and expansion. Recent and long-standing commentary and professional organizational posture and policy do not appear to support such a tenet. Organized medicine has repeatedly registered its concern over the possible erosion of the physician's control of therapy, particularly in reference to the issue of drug product selection. 3 " 7 Most recently, commentary on the health-care team concept and the attendant dilemma of legal and societal responsibility for medicine has also surfaced. 8 If this thesis is correct, the approaching physician glut may well have a "rebound" effect on the team concept and, more importantly, on clinical pharmacy's role development and growth. That is, an oversupply of physicians could conceivably result in further entrenchment against clinical pharmacy's expansion, if for no other reasons than conservation of "professional turf" and/or economic survival. Denial of the centrality of medicine's professional and social influence in the structural integrity of health care delivery would be irresponsible and naive.
Perhaps the pharmacy community should begin to focus in on :
1. the fact that we have not solidified or fully identified the uniqueness of our contribution to the team, or reconciled possible competitive role elements with medicine; 2. the fact that clinical practice has not yet become integrated into and/or sanctioned in institutional practice on a national level -perhaps as a result of lack of prioritization or planned direction in legitimate role expansion, or both; 9 » 10 3. the possibility that the barrier to true integration into the team may become even more formidable, given our relatively nebulous and sometimes inconsistent contributions as team members; 4. the fact diat other "physician extenders" will continue to seek such role expansion and legitimization -a complicating and possibly negative factor in such dynamics; and, 5. developments that suggest that pharmacy educators have used medicine's clinical educational model as a complete template, resulting in clinical practice specialization and even subspecialization with attendant loss of professional identity. Such indulgence in games of professional "Simon Says . . ." may prove counterproductive. The leadership in pharmacy education and practice might well choose to immediately address these matters within the context of medicine's impending manpower problem and approach plans for accommodation, since it might well have a significant effect on die future of clinical pharmacy. PAUL G. PIERPAOLI, M.S.
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Biomédical Journal Uniformity, Double Issue, and Other New Developments
READERS OF Dicp will notice some new developments beginning with this issue. The most obvious new aspect is the initiation of a double issue for the months of July and August. Also readily apparent are two new columns : "Research Methodology" and "Current Therapeutic Findings." Not so conspicuous are style changes that concern authors (see "Author's Guidelines," page 379).
Authors Guidelines
Authors and editors frequently have a difficult time with one another. Authors would like to be able to submit manuscripts to a variety of journals and use the same style with each submission. Editors like to give their journals a distinctive appearance, so that no two look alike. This has contributed to differences in the requirements for submission of manuscripts that are given to authors. Now some medical journal editors are attempting to establish uniformity in the requirements for manuscripts. A group of 19 editors from prestigious medical journals, which are published in the USA, Canada and England, served as founders of a document entitled: "Uniform Requirements for Manuscripts Submitted to Biomédical Journals." This document was approved by the International Steering Committee of Medical Editors February 5, 1979, and has been published in several leading journals. Effective widi this issue, DICP will require all authors to conform to the "Uniform Requirements . . . ," and will begin phasing in style changes. Then, by the January 1980 issue, DICP will be completely converted in appearance, and it is less likely that authors will be annoyed by not knowing which style to follow when submitting a manuscript.
Double Issue
Over the past few years the editors of DICP have discussed the idea of converting to a double issue for the months of July and August as a measure to offset such inflationary costs as postage and paper. This measure has been put into effect with this issue and will continue in subsequent years.
New Column Editors
With this issue, DICP introduces three new column editors, Dr. Dev S. Pathak, who edits the column "Research Methodology," and Dr. Christopher S. Conner and Kelly J. Murphrey, who edit "Current Therapeutic Findings." Dr. Pathak's column was initially described by DICP Board Chairman Don C. McLeod in the April issue. At that time, we had not completed discussions with Conner and Murphrey on their new column; these editors believe their "Current Therapeutic Findings" column will be a valuable resource to clinicians not having rapid access to the literature. By using the reprint address given for each article cited, the reader can send the author a postcard, which requests a reprint, and have a copy of the article within a few days. Many of our readers are not located in medical centers and they should especially appreciate die work of Conner and Murphrey. But even diose readers who have access to sophisticated literature retrieval systems should find this column a useful alerting mechanism. HARVEY A. K. W H I T N E Y , JR.
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